Tamsulosin DRS

FDA expedites Aspen's prostate drug ahead of merger
BioPharma Dive
Thu, 08/18/16 - 04:52 pm
FDA
Aspen Park Pharmaceuticals
Tamsulosin DRS
M&A
benign prostatic hyperplasia